Xuefeng Liu

22.6k total citations · 1 hit paper
192 papers, 6.0k citations indexed

About

Xuefeng Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xuefeng Liu has authored 192 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 43 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Xuefeng Liu's work include Epigenetics and DNA Methylation (18 papers), Bladder and Urothelial Cancer Treatments (14 papers) and Cancer Cells and Metastasis (13 papers). Xuefeng Liu is often cited by papers focused on Epigenetics and DNA Methylation (18 papers), Bladder and Urothelial Cancer Treatments (14 papers) and Cancer Cells and Metastasis (13 papers). Xuefeng Liu collaborates with scholars based in United States, China and Germany. Xuefeng Liu's co-authors include Richard Schlegel, Hang Yuan, Aleksandra Dakic, Hanyujie Kang, Zhaohui Tong, Yishan Wang, Sandra Chapman, Alison A. McBride, Xinghuan Wang and Yu Xiao and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Xuefeng Liu

184 papers receiving 5.9k citations

Hit Papers

ROCK Inhibitor and Feeder Cells Induce the Conditional Re... 2011 2026 2016 2021 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
    2011 554 citations Xuefeng Liu, Bhaskar Kallakury et al. profile →

Peers

Xuefeng Liu
Xiaojun Ma China
Rifat Hamoudi United Kingdom
Bo Zheng China
Sylvie Ricard‐Blum France
Lin Yang China
Arinobu Tojo Japan
Qiang Ding China
Aloysius J. Klingelhutz United States
Ashok Srinivasan United States
Rui Zhao China
Xiaojun Ma China
Xuefeng Liu
Citations per year, relative to Xuefeng Liu Xuefeng Liu (= 1×) peers Xiaojun Ma

Countries citing papers authored by Xuefeng Liu

Since Specialization
Citations

This map shows the geographic impact of Xuefeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Liu more than expected).

Fields of papers citing papers by Xuefeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Liu. The network helps show where Xuefeng Liu may publish in the future.

Co-authorship network of co-authors of Xuefeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Liu. A scholar is included among the top collaborators of Xuefeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Liu. Xuefeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Kai, et al.. (2024). Modeling respiratory tract diseases for clinical translation employing conditionally reprogrammed cells. SHILAP Revista de lepidopterología. 3(6). 100201–100201. 3 indexed citations
2.
Tang, Xinming, Lin Liang, Jiabo Ding, et al.. (2024). Viral metagenomic analysis reveals potential biological hazards in non‐human primates in a zoo. SHILAP Revista de lepidopterología. 3(2). 217–228.
3.
Bhateja, Priyanka, Xuefeng Liu, Sujith Baliga, et al.. (2024). Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers. Journal of Medical Virology. 96(11). e70086–e70086.
4.
Zhang, Haining, et al.. (2024). Numerical simulations of the acoustic and electrical properties of digital rocks based on tetrahedral unstructured mesh. Journal of Geophysics and Engineering. 21(5). 1574–1583. 1 indexed citations
5.
Liu, Xuefeng, et al.. (2024). Two‐ and 3‐year outcomes in convalescent individuals with COVID‐19: A prospective cohort study. Journal of Medical Virology. 96(4). e29566–e29566. 7 indexed citations
6.
Liu, Xuefeng, et al.. (2024). Mitochondrial-targeting strategies with homoharringtonine: A novel approach for chemoresistant rectal cancer. Biochemical and Biophysical Research Communications. 743. 151141–151141. 1 indexed citations
7.
Bonam, Srinivasa Reddy, et al.. (2023). BRD4 as a potential target for human papillomaviruses associated cancer. Journal of Medical Virology. 95(12). e29294–e29294. 1 indexed citations
8.
Liu, Xuefeng, et al.. (2023). Effect and safety of mesenchymal stem cells for patients with COVID‐19: Systematic review and meta‐analysis with trial sequential analysis. Journal of Medical Virology. 95(4). e28702–e28702. 6 indexed citations
9.
Baliga, Sujith, Vedat Yildiz, Alexander A. Farag, et al.. (2023). Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer. Journal of Medical Virology. 95(12). e29293–e29293.
10.
Liu, Xuefeng, et al.. (2023). Can inspiratory muscle training benefit patients with COVID‐19? A systematic review and meta‐analysis. Journal of Medical Virology. 95(8). e28956–e28956. 10 indexed citations
11.
Dakic, Aleksandra, Megan E. Spurgeon, Bhaskar Kallakury, et al.. (2022). AIB1 is a novel target of the high‐risk HPV E6 protein and a biomarker of cervical cancer progression. Journal of Medical Virology. 94(8). 3962–3977. 7 indexed citations
12.
Liu, Xuefeng, Jie Chen, Bowen Wang, et al.. (2022). Effects on community composition and function Pinus massoniana infected by Bursaphelenchus xylophilus. BMC Microbiology. 22(1). 157–157. 8 indexed citations
13.
Zhou, Dawei, Guillaume Fiches, Xuefeng Liu, et al.. (2021). Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination. PLoS Pathogens. 17(7). e1009764–e1009764. 10 indexed citations
14.
Zhang, Zheng, Longhui Qiu, Shixian Yan, et al.. (2019). A clinically relevant murine model unmasks a “two-hit” mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant. American Journal of Transplantation. 19(9). 2421–2433. 22 indexed citations
15.
Liu, Xuefeng, Jan Blancato, Bassem R. Haddad, et al.. (2018). Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. Disease Models & Mechanisms. 11(1). 21 indexed citations
16.
Li, Zhipeng, Jipei Liao, Zejia Yang, et al.. (2018). Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer. 120(3). 306–316. 13 indexed citations
17.
Zhang, Yanting, Rena G. Lapidus, Peiyan Liu, et al.. (2016). Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA. Molecular Cancer Therapeutics. 15(7). 1504–1514. 32 indexed citations
18.
Selvanathan, Saravana P., Garrett T. Graham, Hayriye V. Erkizan, et al.. (2015). Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proceedings of the National Academy of Sciences. 112(11). E1307–16. 105 indexed citations
19.
Liu, Xuefeng, Qiaoling Ruan, Lingyun Shao, et al.. (2015). The tuberculosis prevalence and risk factors among silicotic patients. 33(5). 276–280. 2 indexed citations
20.
Assefnia, Shahin, Keunsoo Kang, Svenja Groeneveld, et al.. (2014). Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer. Endocrine Related Cancer. 21(3). 443–457. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojun Ma Breakdown of academic impact, for papers by Rifat Hamoudi Breakdown of academic impact, for papers by Bo Zheng Breakdown of academic impact, for papers by Sylvie Ricard‐Blum Breakdown of academic impact, for papers by Lin Yang Breakdown of academic impact, for papers by Arinobu Tojo Breakdown of academic impact, for papers by Qiang Ding Breakdown of academic impact, for papers by Aloysius J. Klingelhutz Breakdown of academic impact, for papers by Ashok Srinivasan Breakdown of academic impact, for papers by Rui Zhao
Rankless by CCL
2026